Niton (Nimodipine)

Nimodipine blocks L‑type calcium channels in the smooth muscle of cerebral arteries. This inhibition reduces calcium‑driven contraction, causing the vessels to relax and dilate, which increases cerebral perfusion without markedly lowering systemic blood pressure.

The dosage of Niton is determined by the prescribing clinician based on the patient’s condition, weight, and clinical response. Specific dosing regimens are individualized and should follow the prescribing information provided by the healthcare professional.

Safety data for nimodipine in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To order Niton, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where required) and necessary import documentation.

Nimodipine is distinguished by its high lipophilicity, which enables rapid penetration of the blood‑brain barrier and selective cerebral vasodilation. Other calcium channel blockers, such as nicardipine, are less brain‑specific and are often used for systemic blood pressure control rather than targeted prevention of cerebral vasospasm.

Niton must be stored at 2‑8 °C in a refrigerator. Keep the vial in its original packaging, protect it from light, and avoid freezing or shaking. Once removed from refrigeration, use the product within the time frame specified in the labeling.

Niton is supplied as a sterile injection for intravenous use. It is administered by a healthcare professional under aseptic conditions, typically as an infusion over a prescribed period, with continuous monitoring of vital signs during and after administration.

The most serious adverse events include severe hypotension, which can lead to syncope or shock, cardiac arrhythmias such as bradycardia, and hypersensitivity reactions ranging from rash to anaphylaxis. Prompt recognition and management of these events are essential.

Niton is contraindicated in patients with known hypersensitivity to nimodipine or any component of the formulation, and in those with severe uncontrolled hypotension. Caution is also advised for individuals with significant hepatic impairment or those taking interacting medications that could exacerbate hypotension.